Logo of BIofidus AG

Developability studies

The journey from discovery to commercialization of new biopharmaceutical drugs is always time-consuming and costly. In this respect, it is of utmost importance to determine decisive factors for a successful lead selection such as manufacturability, biophysical properties and pharmacokinetics as quickly as possible in order to ensure a targeted development.

Biofidus provides a holistic and state-of-the-art developability assessment service for your lead candidates, to accelerate your pipeline and to minimize the risk of later stage setbacks. Our assessment provides a bridge between product knowledge and process understanding. Our developability assessment helps you to optimize the efficacy, safety and overall quality of your biologics at an early stage of development.

Our vast experience and deep knowledge in this field allows us to guide you through the variety of available methods and help you find the optimal analytical solution for your project.

In accordance with your needs, we adapt and, if required, qualify (according to ICH guidelines) our platform methods tailored to your drug substance, its individual formulation matrix and your distinct analytical question.

Get in contact with us to quickly find the optimal setup for your analytical challenge and to speak directly from expert to expert.

Our capabilities

Standalone and integral bioanalytical services

Protein Sequence Analysis

PROTEIN SEQUENCE ANALYSIS

Impurity Analysis
IMPURITY ANALYSIS
Amino Acid Modifications
AMINO ACID (AA) MODIFICATIONS
Aggregation Analysis
AGGREGATION ANALYSIS
Charge Heterogenity
CHARGE HETEROGENITY
Bioactivity
BIOACTIVITY STUDIES
Higher Order Structure
HIGHER ORDER STRUCTURE CHARACTERIZATION
lycosylation Analysis
GLYCOSYLATION ANALYSIS
CE Analysis
CE ANALYSIS
Cellbased Assay
CELL BASED ASSAYS
SPR Analysis
SPR ANALYSIS

Tell us about your project

We‘ll advice you to define your assay needs

By sending the contact form you agree to our privacy policy.
*By submitting this form, you are consenting to receive emails from: Biofidus AG. You can revoke your consent at any time by using the unsubscribe link, found at the bottom of every email. Please see our privacy policy.

Technologies used

Our CEO Dr. Benjamin Müller advices you on all inquiries concerning our developability assessments.

Phone: +49(0)521 89 739 060
Mail: Benjamin.Mueller@Biofidus.com

WordPress Cookie Plugin von Real Cookie Banner